Sumatriptan Succinate Injection
Product Images NDC 46708-656

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 46708-656). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sumatriptan-4mg-carton-1s (Sumatriptan 4mg Carton 1s)

This is information about Sumatriptan Injection, an autoinjector system containing 4 mg/0.5 mL of the solution for subcutaneous injection. The instructions guide the user on how to administer the injection correctly. The product is manufactured by Alembic Pharmaceuticals Limited in India and contains Sumatriptan succinate and sodium chloride. It is important to store the product between 2° and 30°C, protect it from light, and retain it in the carton until used. The carton includes one autoinjector with a prefilled syringe, along with prescribing and patient information.*

FDA Label Image

Sumatriptan-4mg-carton-2s (Sumatriptan 4mg Carton 2s)

This text is a label for Sumatriptan Injection, USP in 0.5 mL prefilled syringes intended for subcutaneous injection. It provides instructions on how to use the autoinjector system and store the medication properly. The label also includes prescribing information, dosage details, and manufacturer details. Please note it is for single-dose use and should be kept between 2° and 30°C.*

FDA Label Image

Sumatriptan-4mg-pen-label (Sumatriptan 4mg Pen Label)

This is a description for a Single Dose Autoinjector System containing a prefilled syringe with 0.5 mL solution. The autoinjector contains 5.6mg of sumatriptan succinate, equivalent to 4 mg of sumatriptan, and 3.8 mg of sodium chloride. The product is sterile, nonpyrogenic, and should be stored between 2° and 30°C (36° and 86°F). It is intended for subcutaneous injection and should be protected from light. Manufactured by Alembic Pharmaceuticals Limited in India.*

FDA Label Image

Sumatriptan-4mg (Sumatriptan 4mg)

FDA Label Image

Sumatriptan-6mg-carton-1s (Sumatriptan 6mg Carton 1s)

This text appears to be a detailed description of a medication product, likely an injectable solution of sumatriptan succinate with instructions for use. It specifies that the prefilled syringe is for subcutaneous injection only, contains 0.5 mL solution with a specific dosage of sumatriptan succinate and sodium chloride, and should be stored at a specific temperature range. It also mentions the manufacturer, Alembic Pharmaceuticals Limited. Please refer to the full prescribing information for dosage and administration details.*

FDA Label Image

Sumatriptan-6mg-carton-2s (Sumatriptan 6mg Carton 2s)

This is a detailed description of a medication called Sumatriptan Injection, USP. It is intended for subcutaneous injection only and contains 6 mg of sumatriptan in a 0.5 mL prefilled syringe. The instructions for use and patient information are provided in the packaging. The medication should be stored between 2°C and 30°C (35°F and 86°F) and kept protected from light until use. The product is sterile, nonpyrogenic, and manufactured by Alembic Pharmaceuticals Ltd. in India. The packaging includes 2 autoinjectors with prefilled syringes and prescribing information.*

FDA Label Image

Sumatriptan-6mg-pen-label (Sumatriptan 6mg Pen Label)

This is a description of a Single Dose Autoinjector System containing sumatriptan Injection, USP. Each autoinjector has a prefilled syringe with 0.5 mL solution containing 8.4 mg of sumatriptan succinate, equivalent to 6 mg of sumatriptan, and 3.5 mg of sodium chloride. It is sterile, nonpyrogenic, and should be stored between 2° and 30°C (36° and 86°F) for subcutaneous use. The product should be protected from light. Manufactured by Alembic Pharmaceuticals Limited in India. The product has a lot number and an expiry date of 11/2024.*

FDA Label Image

Sumatriptan-6mg (Sumatriptan 6mg)

FDA Label Image

Sumatriptan-features2 (Sumatriptan Features2)

This text appears to provide instructions for the use of a pre-filled auto-injector for injecting medication. It includes steps like removing the cap before injection and after injection. The text seems to contain typographical errors making the exact meaning unclear. Additional context or a corrected version may be needed for a more accurate interpretation.*

FDA Label Image

Sumatriptan-figure-1 (Sumatriptan Figure 1)

This text provides data on the estimated percentage of patients experiencing relief within a specific time frame with a placebo and sumatriptan. The data is given for 100 patients in the placebo group and 131 patients in the sumatriptan group over a span of 10 to 25 minutes.*

FDA Label Image

Sumatriptan-ifu-fig-a (Sumatriptan Ifu Fig A)

FDA Label Image

Sumatriptan-ifu-fig-b (Sumatriptan Ifu Fig B)

FDA Label Image

Sumatriptan-ifu-fig-c (Sumatriptan Ifu Fig C)

FDA Label Image

Sumatriptan-ifu-fig-d (Sumatriptan Ifu Fig D)

FDA Label Image

Sumatriptan-ifu-fig-e (Sumatriptan Ifu Fig E)

FDA Label Image

Sumatriptan-ifu-fig-f (Sumatriptan Ifu Fig F)

FDA Label Image

Sumatriptan-ifu-fig-g (Sumatriptan Ifu Fig G)

FDA Label Image

Sumatriptan-ifu-fig-h (Sumatriptan Ifu Fig H)

FDA Label Image

Sumatriptan-ifu-fig-i (Sumatriptan Ifu Fig I)

FDA Label Image

Sumatriptan-ifu-fig-j. (Sumatriptan Ifu Fig J)

FDA Label Image

Sumatriptan-ifu-fig-k (Sumatriptan Ifu Fig K)

FDA Label Image

Sumatriptan-structure (Sumatriptan Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.